A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion
Clinical trial NCT04459338 · COMPLETED
Trial details
- NCT number
- NCT04459338
- Sponsor
- Adrian Vella
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2022-06-14
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.